Digital health funding has surged to US$7.4 billion in the first half of 2026, marking a significant increase driven by advancements in artificial intelligence (AI). This uptick follows a reset period post-pandemic, with investments exceeding the US$6.4 billion raised during the same period in 2025.
The report from Rock Health indicates that there were 244 digital health transactions in the first six months of the year, with US$3.2 billion allocated in the second quarter alone. This shift reflects evolving investor expectations as AI transforms the competitive landscape. Rock Health emphasizes that as foundational AI models become more accessible, the focus is shifting from merely having AI capabilities to offering unique solutions that AI cannot replicate.
Key themes emerging in this new AI-driven environment include the importance of domain expertise, ownership of clinical workflows, active delivery models, and the value of partnerships. Notably, 19 companies secured significant funding through 20 megadeals, accounting for 45% of total investments. Mental health continues to be the leading area for funding, with substantial rounds for companies like Talkiatry and Grow Therapy, while the weight management sector is also gaining traction, particularly due to the popularity of GLP-1 drugs.
As the digital health landscape evolves, the insights from Rock Health suggest that founders with deep industry knowledge are better positioned to identify and solve critical healthcare challenges. The focus on founder-market fit highlights the importance of understanding both the business and the operational culture of healthcare providers, which may shape the future success of digital health initiatives.